Abstract:Background Amyloid plaque is one of the pathological hallmarks of Alzheimer's disease (AD). Anti⁃beta⁃amyloid (Aβ) immunotherapy is effective in removing brain Aβ, but has shown to be associated with detrimental effects. To avoid severe adverse effects such as meningoencephalitis induced by amyloid beta vaccine with adjuvant, and take advantage of amyloid beta antibody's therapeutic effect on Alzheimer's disease sufficiently, our group has developed a new Alzheimer vaccine with mutated amyloid beta 1-42 peptide stimulating dendritic cells (DC). Our previous work has confirmed that DC vaccine can induce adequate anti⁃amyloid beta antibody in PDAPP Tg mice safely and efficiently. The DC vaccine can improve impaired learning and memory in the Alzheimer's animal model, and did not cause microvasculitis, microhemorrhage or meningoencephalitis in the animal model. However, the exact mechanism of immunotherapy which reduces Aβ deposition remains unknown. In this report, we studied the mechanism of the vaccine, thinking that this may have implications for better understanding of the pathogenesis of Alzheimer's disease. Methods A new Alzheimer vaccine with mutated amyloid beta 1-42 peptide stimulating DC which were obtained from C57/B6 mouse bone marrow was developed. Amyloid beta with Freund's adjuvant was inoculated at the same time to act as positive control. After the treatment was done, the samples of brains were collected, fixed, cut. Immunohistochemical staining was performed to observe the expression of the nuclear hormone liver X receptor (LXR), membrane ⁃ bound protein tyrosine phosphatase (CD45), the ATP⁃binding cassette family of active transporters (ABCA1), receptor for advanced glycation end products (RAGE), β⁃site APP⁃cleaving enzyme (BACE) and Aβ in mouse brain tissue. Semi⁃ quantitative analysis was used to defect CA1, CA2, CA3, DG, Rad in hippocampus region and positive neuron in cortex region. Results Aβ was significantly reduced in the experimental group and the positive control group (P = 0.000), but no changes were seen in the negative control group. The levels of LXR, ABCA1, CD45, BACE expression were significantly higher in the PFDM group with DC vaccine treatment and the levels of RAGE were lower than those in the control group. Conclusion The reduction of Aβ via the DC vaccine occurs through multiple factors to achieve a new immune balance. The beneficial results of DC vaccine, which did not produce side effects, may be caused by the LXR/ABCA1 path. DC alone may play an important role in clearing the Aβ to prevent the occurrence of adverse reaction. DOI：10.3969/j.issn.1672⁃6731.2012.03.016

Inhibition of autophagosome-lysosome fusion contributes to TDCIPP-induced Aβ1-42 production in N2a-APPswe cells

A quantitative proteomic study reveals oxidative stress and synapse-related proteins contributed to TDCIPP exposure induced neurotoxicity

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.

Elevated amyloidoses of human IAPP and amyloid beta by lipopolysaccharide and their mitigation by carbon quantum dots

APP β-CTF triggers cell-autonomous synaptic toxicity independent of Aβ

Lysosomal TPCN (two pore segment channel) inhibition ameliorates beta-amyloid pathology and mitigates memory impairment in Alzheimer disease

A protective role of autophagy in TDCIPP-induced developmental neurotoxicity in zebrafish larvae.

Influence of Chlorpyrifos Oxon on the Development and Progression of Alzheimer′s Disease in Amyloid Precursor Protein Transgenic Mice

Tdp-43 Interaction with the Intracellular Domain of Amyloid Precursor Protein Induces P53-Associated Apoptosis

The Role and Mechanism of Ambra1-Mediated Mitophagy in TDCPP-Exposed Mouse Hippocampal Neurons

Tetramethylpyrazine Nitrone (TBN) Reduces Amyloid β Deposition in Alzheimer's Disease Models by Modulating APP Expression, BACE1 Activity, and Autophagy Pathways

P2‐142: Toxic Effect of the Carboxyl‐terminal Peptide of Beta‐amyloid Precursor Protein (APPC31) on Neuro2a Cells

Autophagy-ERK1/2-Involved Disinhibition of Hippocampal Neurons Contributes to the Pre-Synaptic Toxicity Induced by Aβ42 Exposure.

The Role of Mutated Amyloid Beta 1⁃42 Stimulating Dendritic Cells in a PDAPP Transgenic Mouse

Daphnetin Ameliorates Aβ Pathogenesis Via STAT3/GFAP Signaling in an APP/PS1 Double-Transgenic Mouse Model of Alzheimer's Disease.

Cu(II) disrupts autophagy-mediated lysosomal degradation of oligomeric Aβ in microglia via mTOR-TFEB pathway

Tβ4 and PDTC displayed recovery on the glial and neuronal alterations in an early Alzheimer’s disease model

NPD1 Enhances Autophagy and Reduces Hyperphosphorylated Tau and Amyloid-beta(42) by Inhibiting GSK3 beta Activation in N2a/APP695swe Cells

Proteomic Analysis Reveals the Potential Neuroprotective Effects of Tetramethylpyrazine Dimer in Neuro2a/appswe Cells

Organophosphorus flame retardant TDCPP induces neurotoxicity via mitophagy-related ferroptosis in vivo and in vitro